ACP-104

· ACADIA Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ACP-104, covering 2011-06-28 to 2025-01-20. Get the full timeline:

Most recent: Clinical Trial Update: ACP-104 in Acutely Psychotic Subjects With Schizophrenia [Phase 2]